You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Tumor immunogenicity

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tumor Immunogenicity Modulation in Cervical Cancer

Recruiting
  • Cervical Cancer
  • Benign Tumor of Uterus
    • Shantou, Guangdong, China
      Cancer Hospital of Shantou University Medical College
    Dec 27, 2021

    Advanced Solid Tumor Trial in Beijing (QLF3108)

    Recruiting
    • Advanced Solid Tumor
    • Beijing, Beijing, China
      Chinese People's Liberation Army (PLA) General Hospital
    Aug 29, 2023

    Advanced Solid Tumors Trial in Shanghai (QLS31903)

    Recruiting
    • Advanced Solid Tumors
    • Shanghai, Shanghai, China
      Fudan Zhongshan Hospital
    Apr 20, 2023

    IBD, Biological Substance; Adverse Effect Trial in Haifa (Azithromycin Pill, Placebo)

    Not yet recruiting
    • Inflammatory Bowel Diseases
    • Biological Substance; Adverse Effect
    • Azithromycin Pill
    • Placebo
    • Haifa, Israel
      Rambam Health Care Campus
    Oct 25, 2022

    Advanced Solid Tumor Trial in Beijing (LK101 injection)

    Recruiting
    • Advanced Solid Tumor
    • LK101 injection
    • Beijing, Beijing, China
    • +1 more
    Sep 22, 2023

    Advanced Solid Tumor Trial (HS-20093)

    Not yet recruiting
    • Advanced Solid Tumor
    • (no location specified)
    Oct 29, 2023

    Advanced Solid Tumors Trial (QLP2117)

    Not yet recruiting
    • Advanced Solid Tumors
    • (no location specified)
    Apr 24, 2023

    Solid Tumor, Adult Trial in Xi'an (Bio-008)

    Recruiting
    • Solid Tumor, Adult
    • Bio-008
    • Xi'an, Shaanxi, China
      The First Affiliated Hospital of the Chinese People's Liberation
    Aug 30, 2023

    Advanced Solid Tumor Trial in Hangzhou (BR101)

    Recruiting
    • Advanced Solid Tumor
    • Hangzhou, Zhejiang, China
      The Second Affiliated Hospital of Zhejiang University Medical Co
    Aug 14, 2023

    Solid Tumor Trial in Shanghai (LB4330)

    Recruiting
    • Solid Tumor
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Jan 31, 2023

    HER2-positive Advanced Solid Tumor Trial in Zigong (ZV0203)

    Enrolling by invitation
    • HER2-positive Advanced Solid Tumor
    • Zigong, Shandong, China
      PKUCare Luzhong Hospital
    Jun 14, 2022

    Immunogenicity of TNF Inhibitors in Arthritis Poorer Treatment

    Recruiting
    • Arthritis, Rheumatoid
    • +2 more
      • Aalborg, Denmark
        Department of rheumatology
      Sep 1, 2022

      Solid Tumor, Lymphoma Trial (LB1410)

      Recruiting
      • Solid Tumor
      • Lymphoma
      • Shanghai, Shanghai, China
        Shanghai Pulmonary Hospital
      Dec 27, 2022

      Solid Tumor Malignancy, Hematologic Malignancy, Leukemia Trial run by the NCI (mrna 1273 injection)

      Recruiting
      • Solid Tumor Malignancy
      • +4 more
      • mRNA-1273
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 14, 2023

      Advanced EGFR Positive Solid Tumor Trial in China, United States (ZZ06)

      Recruiting
      • Advanced EGFR Positive Solid Tumor
      • ZZ06
      • Los Angeles, California
      • +3 more
      Mar 7, 2022

      Lynch Syndrome Trial in Puerto Rico, United States (Adenoviral Tumor-specific Neoantigen Priming Vaccine GAd-209-FSP, MVA

      Recruiting
      • Lynch Syndrome
      • Adenoviral Tumor-specific Neoantigen Priming Vaccine GAd-209-FSP
      • +2 more
      • Duarte, California
      • +3 more
      Nov 22, 2022

      HPV-Related Squamous Cell Carcinoma, HNSCC Trial in London (VB10.16, Pembrolizumab)

      Not yet recruiting
      • HPV-Related Squamous Cell Carcinoma
      • HNSCC
      • London, United Kingdom
        East and North Hertfordshire NHS Trust Mount Vernon Hospital
      Aug 24, 2023

      Chemo-induced Thrombocytopenia (CIT) Trial in Chengdu (Recombinant Human Tumor Necrosis Factor Receptor II -Fc-TPO Mimetic

      Recruiting
      • Chemotherapy-induced Thrombocytopenia (CIT)
      • Recombinant Human Tumor Necrosis Factor Receptor II -Fc-TPO Mimetic Peptide Fusion Protein
      • Chengdu, Sichuan, China
        West China Hospital of Sichuan University
      Jun 23, 2022

      Pulmonary Fibrosis, Tumor Trial in Randwick (9MW3811 injection, Placebo)

      Not yet recruiting
      • Pulmonary Fibrosis
      • Tumor
      • 9MW3811 injection
      • Placebo
      • Randwick, New South Wales, Australia
        Scientia Clinical Research
      Feb 13, 2023

      Advanced Solid Tumor Trial in Melbourne (LM-302, Toripalimab)

      Enrolling by invitation
      • Advanced Solid Tumor
      • Melbourne, Australia
        The Alfred
      May 20, 2022

      Solid Tumor Trial (Neoantigen mRNA Personalised Cancer SW1115C3)

      Not yet recruiting
      • Solid Tumor
      • Neoantigen mRNA Personalised Cancer SW1115C3
      • (no location specified)
      Feb 7, 2022

      Tumor Trial in Shanghai (SIBP-03)

      Recruiting
      • Tumor
      • SIBP-03
      • Shanghai, Shanghai, China
        Fudan University Shanghai Cancer Center
      Jan 23, 2022

      Solid Tumor, Adult Trial in Miami (ASV® AGEN2017 + QS-21 Stimulon® adjuvant)

      Completed
      • Solid Tumor, Adult
      • ASV® AGEN2017 + QS-21 Stimulon® adjuvant
      • Miami, Florida
        School of Medicine at the University of Miami
      Dec 1, 2021

      Metastatic Colorectal Cancer, Solid Tumor Trial in Chonam, Gyeonggi-do, Seoul (irinotecan, FOLFIRI)

      Completed
      • Metastatic Colorectal Cancer
      • Solid Tumor
      • Chŏnam, Korea, Republic of
      • +5 more
      Mar 1, 2022

      Diffuse Hemispheric Glioma, H3 G34-Mutant Trial in Los Angeles (biological, procedure, drug)

      Not yet recruiting
      • Diffuse Hemispheric Glioma, H3 G34-Mutant
      • Dendritic Cell Tumor Peptide Vaccine
      • +6 more
      • Los Angeles, California
        UCLA / Jonsson Comprehensive Cancer Center
      Jul 13, 2022